1. Cytokine combinations in immunotherapy for solid tumors: a review

   • Keith M. Heaton
   • Elizabeth A. Grimm

   Review Pages: 213 - 219

2. Cytotoxic cell function and phenotypic analysis of peripheral blood mononuclear cells in cancer patients treated with low-dose interleukin-2 and mitomycin C

   • Shinya Arinaga
   • Nobuya Karimine
   • Tsuyoshi Akiyoshi

   Original Articles Pages: 220 - 226

3. Interleukin-5 induces tumor suppression by peritoneal exudate cells in mice

   • Yasunari Nakashima
   • Seiji Mita
   • Michio Ogawa

   Original Articles Pages: 227 - 232

4. Effect of allogeneic tumor cells, interleukin-2 and interleukin-6, on the growth of subcutaneous syngeneic tumors

   • Avi Eisenthal
   • Yehuda Skornick
   • Samario Chaitchik

   Original Articles Pages: 233 - 239

5. In vitro expansion and analysis of T lymphocyte microcultures obtained from the vaccination sites of cancer patients undergoing active specific immunization with autologous Newcastle-disease-virus-modified tumour cells

   • M. Stoeck
   • C. Marland-Noske
   • V. Schirrmacher

   Original Articles Pages: 240 - 244

6. Synergetic effect of interleukin-2 and cellular cytotoxicity against a novel tumor-associated carbohydrate antigen Le^a/Le^a (dimeric Le^a) mediated by monoclonal antibody NCC-ST-421 in adoptive immunization using SCID mice

   • Masahiko Watanabe
   • Tetsuro Kubota
   • Sen-itiroh Hakomori

   Original Articles Pages: 245 - 250

7. Inhibition of prostaglandin E₂ formation and histamine action in cancer immunotherapy

   • Pekka Uotila

   Original Articles Pages: 251 - 254

8. Differential responses of human tumor cell lines to anti-p185^HER2 monoclonal antibodies

   • Gail D. Lewis
   • Irene Figari
   • H. Michael Shepard

   Original Articles Pages: 255 - 263

9. Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab₁)

   • J. Fagerberg
   • J-E. Frödin
   • H. Mellstedt

   Original Articles Pages: 264 - 270

10. Critical factors for liposome-incorporated tumour-associated antigens to induce protective tumour immunity to SL2 lymphoma cells in mice

    • Joep J. Bergers
    • Willem Den Otter
    • Daan J. A. Crommelin

    Original Articles Pages: 271 - 279